Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cellulose acetate dialyzer expiration dating may be required; FDA issues alert following patient injuries.

This article was originally published in The Gray Sheet

Executive Summary

CELLULOSE ACETATE DIALYZER EXPIRATION DATING REQUIREMENT likely will be developed by FDA in response to recent adverse events with the devices. The events, all occurring in September at a Huntsville, Alabama hospital, are thought to be related to use of 10-year-old cellulose acetate dialyzers to treat seven patients who developed conjunctivitis, visual loss, and/or hearing loss within 24 hours of hemodialysis.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007330

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel